Physician profile
Anna Lim-Kates
NPI 1326476367
$777.92
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $353 · 2021: $55.51 · 2022: $76.48 · 2023: $31.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $31.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $31.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $141.08 | 2019-2022 | |
| Amgen INC. | $82.02 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $72.50 | 2019-2020 | |
| Lilly USA, LLC | $67.65 | 2019-2021 | |
| Amarin Pharma, INC. | $67.38 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $43.66 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $39.96 | 2020-2022 | |
| Alexion Pharmaceuticals, INC. | $38.72 | 2019-2020 | |
| Pfizer INC. | $28.82 | 2020-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.05 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.29 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $25.65 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $23.83 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.31 | 2019 | |
| Ethicon US, LLC | $14.40 | 2023 | Stratafix, Dermabond |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $13.95 | 2019 | |
| Genentech USA, INC. | $13.37 | 2020 | |
| Abbott Laboratories | $12.91 | 2021 | |
| Glaxosmithkline, LLC. | $12.60 | 2022 | |
| Currax Pharmaceuticals LLC | $8.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Lim-Kates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.